Top Markets
Coin of the day
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Pozycja w akcjach #28871
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Cena akcji
$0.9142
Kapitalizacja rynkowa
$23.77M
Zmiana (1 dzień)
5.55%
Zmiana (1 rok)
-67.92%
Kraj
US
Handel ABVC BioPharma, Inc. (ABVC)

Kategoria

Historia ceny akcji dla ABVC BioPharma, Inc. (ABVC)
Najwyższa cena zamknięcia: $0.94 dnia 2026-08-01

Najniższa cena zamknięcia: $455.54K dnia 2004-11-01
Historia cen akcji firmy ABVC BioPharma, Inc. od 2004 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -15.73%
2025 331.39%
2024 -56.69%
2023 -82.53%
2022 -79.50%
2021 -27.15%
2020 -18.60%
2019 -79.88%
2018 -21.05%
2017 0.00%
2016 -74.88%
2015 -42.11%
2014 -17.94%
2013 -48.16%
2012 -81.81%
2011 -12.18%
2010 -91.16%
2009 -58.61%
2008 -66.11%
2007 -5.25%
2006 160.11%
2005 191.95%
2004 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$543.61 39.12%
US
$1.02K 55.86%
NL
$141.85 408.24%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH